Pfizer will acquire Metsera in a deal worth $4.9 billion up front and up to $7.3 billion if the acquired assets succeed further. Metsera is developing anti-obesity treatments that could differentiate ...
Fans of reMarkable’s series of notepad-like note-taking E-Ink tablets have something new to get excited about today: a new version of the devices called the reMarkable Paper Pro Move, which takes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback